ArticleThe Journal of dermatology2025
Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long-Term Treatment Outcomes.
Article in The Journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Therapeutic Outcomes of Janus Kinase Inhibitors in Refractory Nail Lichen Planus: A Systematic Review.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nail lichen planus (NLP) is a rare, chronic inflammatory nail disorder that can result in irreversible damage. While clinical awareness is growing, long-term real-world data-particularly incorporating histopathological confirmation and treatment outcomes-remains limited. We retrospectively analyzed 81 biopsy-confirmed NLP cases (2016-2024) from a Chinese dermatology center to characterize their epidemiological, clinical, histological features, treatment responses, and long-term outcomes. The mean age at onset of our cohort was 44.41 ± 17.77 years, with a slight male predominance (59.26%). Nail matrix involvement occurred in 97.53% of patients, and disease severity did not correlate with disease duration. Longitudinal biopsies showed a 96.30% concordance rate between clinical and histopathologic localization and revealed ventral proximal nail fold inflammation in 58.02% of patients. Patient satisfaction with the biopsy procedure was generally high (mean score: 8.32), though 14.52% reported dissatisfaction due to post-procedure deformity. Misdiagnosis occurred in 44.44% of patients. Among 62 patients with treatment follow-up, systemic corticosteroids were the most effective therapy, especially in those with periungual erythema; although 42.86% relapsed after discontinuation. JAK inhibitors demonstrated encouraging results in refractory cases. Oral acitretin showed moderate efficacy in early disease, while topical corticosteroids, calcineurin inhibitors, and hydroxychloroquine were largely ineffective. This study presents the largest long-term cohort of biopsy-confirmed NLP to date and offers new insights into its clinical spectrum, diagnostic strategies, and real-world treatment outcomes. It highlights the utility and limitations of longitudinal biopsy, the potential predictive value of periungual inflammation, and the emerging role of JAK inhibitors as promising therapeutic agents in recalcitrant cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.